Skip to menu Skip to content Skip to footer

2011

Journal Article

Group A streptococcal vaccine candidates based on the conserved conformational epitope from M protein

Skwarczynski, Mariusz, Ahmad Fuaad, Abdullah A. H., Rustanti, Lina, Ziora, Zyta M., Aqil, Mohammed, Batzloff, Michael R., Good, Michael F. and Toth, Istvan (2011). Group A streptococcal vaccine candidates based on the conserved conformational epitope from M protein. Drug Delivery Letters, 1 (1), 2-8. doi: 10.2174/2210304X11101010002

Group A streptococcal vaccine candidates based on the conserved conformational epitope from M protein

2011

Journal Article

Pro-apoptotic activity of lipidic alpha-amino acids isolated from Protopalythoa variabilis (vol 18, pg 7997, 2010)

Wilke, DV, Jimenez, PC, Araujo, RM, da Silva, WMB, Pessoa, ODL, Silveira, ER, Pessoa, C, de Moraes, MO, Skwarczynski, M, Simerska, P, Toth, I and Costa-Lotufo, LV (2011). Pro-apoptotic activity of lipidic alpha-amino acids isolated from Protopalythoa variabilis (vol 18, pg 7997, 2010). Bioorganic and Medicinal Chemistry, 19 (3), 1366-1366. doi: 10.1016/j.bmc.2010.12.041

Pro-apoptotic activity of lipidic alpha-amino acids isolated from Protopalythoa variabilis (vol 18, pg 7997, 2010)

2011

Journal Article

Lipophilic derivatives of leu-enkephalinamide: In vitro permeability, stability and in vivo nasal delivery

Cros, Cecile D., Toth, Istvan and Blanchfield, Joanne T. (2011). Lipophilic derivatives of leu-enkephalinamide: In vitro permeability, stability and in vivo nasal delivery. Bioorganic and Medicinal Chemistry, 19 (4), 1528-1534. doi: 10.1016/j.bmc.2010.12.042

Lipophilic derivatives of leu-enkephalinamide: In vitro permeability, stability and in vivo nasal delivery

2011

Conference Publication

Development of 3-component Mucosal Group A streptococcus (GAS) Vaccine Candidate

Zaman, Mehfuz, Abdel-Aal, Abu-Baker, Fujita, Yoshio, Batzloff, Michael, Good, Michael and Toth, Istvan (2011). Development of 3-component Mucosal Group A streptococcus (GAS) Vaccine Candidate. 22nd American Peptide Symposium, San Diego Ca, Jun 25-30, 2011. MALDEN: WILEY-BLACKWELL.

Development of 3-component Mucosal Group A streptococcus (GAS) Vaccine Candidate

2011

Conference Publication

Dendritic delivery systems for peptide vaccines

Toth, Istvan, Simerska, Pavla and Skwarczynsky, Mariusz (2011). Dendritic delivery systems for peptide vaccines. 1st European Conference of Microbiology and Immunology, Budapest, Hungary, 12-14 May 2011. Budapest, Hungary: Akademiai Kiado. doi: 10.1556/EuJMI.1.2011.2.1

Dendritic delivery systems for peptide vaccines

2011

Journal Article

The eighth Australian peptide conference: Peptides - Tools, targets and therapeutics

Benson, Heather and Toth, Istvan (2011). The eighth Australian peptide conference: Peptides - Tools, targets and therapeutics. Biopolymers, 96 (2), iii-iii. doi: 10.1002/bip.21610

The eighth Australian peptide conference: Peptides - Tools, targets and therapeutics

2011

Book Chapter

Lipid core peptide system for self-adjuvanting synthetic vaccine delivery

Skwarczynski, Mariusz and Toth, Istvan (2011). Lipid core peptide system for self-adjuvanting synthetic vaccine delivery. Bioconjugation protocols: Strategies and methods. (pp. 297-308) edited by Sonny S. S. Mark. New York , U.S.A: Humana Press. doi: 10.1007/978-1-61779-151-2_18

Lipid core peptide system for self-adjuvanting synthetic vaccine delivery

2011

Conference Publication

The influence of incorporating lipids or liposaccharides on the particle size of peptide therapeutics

Coles, Daniel J., Simerska, Pavla, Fujita, Yoshio and Toth, Istvan (2011). The influence of incorporating lipids or liposaccharides on the particle size of peptide therapeutics. 8th Australian Peptide Conference. Peptides: Tools, Targets and Therapeutics, Coran Cove, South Stradbroke Island, QLD, Australia, 11-16 October 2009. Hoboken, NJ, U.S.A.: John Wiley & Sons. doi: 10.1002/bip.21459

The influence of incorporating lipids or liposaccharides on the particle size of peptide therapeutics

2010

Journal Article

Design of three-component vaccines against group A streptococcal infections: Importance of spatial arrangement of vaccine components

Abdel-Aal, Abu-Baker M., Zaman, Mehfuz, Fujita, Yoshio, Batzloff, Michael R., Good, Michael F. and Toth, Istvan (2010). Design of three-component vaccines against group A streptococcal infections: Importance of spatial arrangement of vaccine components. Journal of Medical Chemistry, 53 (22), 8041-8046. doi: 10.1021/jm1007787

Design of three-component vaccines against group A streptococcal infections: Importance of spatial arrangement of vaccine components

2010

Journal Article

Pro-apoptotic activity of lipidic α-amino acids isolated from Protopalythoa variabilis

Wilke, Diego Veras, Jimenez, Paula Christine, Araújo, Renata Mendonça, da Silva, Wildson Max Barbosa, Pessoa, Otília Deusdênia Loiola, Silveira, Edilberto Roch, Pessoa, Claudia, de Moraes, Manoel Odorico, Skwarczynski, Mariusz, Simerska, Paul, Toth, Istvan and Costa-Lotufo, Letícia Veras (2010). Pro-apoptotic activity of lipidic α-amino acids isolated from Protopalythoa variabilis. Bioorganic and Medicinal Chemistry, 18 (22), 7997-8004. doi: 10.1016/j.bmc.2010.09.027

Pro-apoptotic activity of lipidic α-amino acids isolated from Protopalythoa variabilis

2010

Journal Article

Determination of rat 5α-reductase type 1 isozyme activity and its inhibition by novel steroidal oxazolines

Szécsi, M., Ondré, Dóra, Tóth, I., Magony, S., Wölfling, J., Schneider, Gy and Julesz, J. (2010). Determination of rat 5α-reductase type 1 isozyme activity and its inhibition by novel steroidal oxazolines. Acta Biologica Hungarica, 61 (3), 274-281. doi: 10.1556/ABiol.61.2010.3.4

Determination of rat 5α-reductase type 1 isozyme activity and its inhibition by novel steroidal oxazolines

2010

Journal Article

Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system

Skwarczynski, Mariusz, Zaman, Mehfuz, Urbani, Carl N., Lin, I-Chun, Jia, Zhongfan, Batzloff, Michael R., Good, Michael F., Monteiro, Michael J. and Toth, Istvan (2010). Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system. Angewandte Chemie, 122 (33), 5878-5881. doi: 10.1002/ange.201002221

Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system

2010

Journal Article

The synthesis and characterization of lipophilic peptide-based carriers for gene delivery

Coles, DJ, Esposito, A, Chuah, HT and Toth, I (2010). The synthesis and characterization of lipophilic peptide-based carriers for gene delivery. Tetrahedron, 66 (29), 5435-5441. doi: 10.1016/j.tet.2010.05.031

The synthesis and characterization of lipophilic peptide-based carriers for gene delivery

2010

Journal Article

In vitro and in vivo evaluation of positively charged liposaccharide derivatives as oral absorption enhancers for the delivery of anionic drugs

Bergeon, Julie A., Ziora, Zyta M., Abdelrahim, Adel S., Pernevi, Niklas, Moss, Anne R. and Toth, Istvan (2010). In vitro and in vivo evaluation of positively charged liposaccharide derivatives as oral absorption enhancers for the delivery of anionic drugs. Journal of Pharmaceutical Sciences, 99 (5), 2333-2342. doi: 10.1002/jps.21999

In vitro and in vivo evaluation of positively charged liposaccharide derivatives as oral absorption enhancers for the delivery of anionic drugs

2010

Journal Article

Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response

Zaman, Mehfuz, Simerska, Pavla and Toth, Istvan (2010). Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response. Current Drug Delivery, 7 (2), 118-124. doi: 10.2174/156720110791011846

Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response

2010

Journal Article

Structure-activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2

Zaman, M, Abdel-Aal, AM, Phillipps, KSM, Fujita, Y, Good, MF and Toth, I (2010). Structure-activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2. Vaccine, 28 (10), 2243-2248. doi: 10.1016/j.vaccine.2009.12.046

Structure-activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2

2010

Book Chapter

Toll-like receptor 2 mediated dendritic cell activation: Key target for lipopeptide vaccines design

Zaman, Mehfuz, Skwarczynski, Marius and Toth, Istvan (2010). Toll-like receptor 2 mediated dendritic cell activation: Key target for lipopeptide vaccines design. Dendritic Cells: Types, Life Cycles and Biological Functions. (pp. 63-80) edited by Lorraine C. Welles. New York, NY, U.S.A.: Nova Science Publishers.

Toll-like receptor 2 mediated dendritic cell activation: Key target for lipopeptide vaccines design

2010

Book Chapter

Lipopeptide-based vaccines

Jackson, David C., Chua, Brendon Y., Brown, Lorena E., Moyle, Peter and Toth, Istvan (2010). Lipopeptide-based vaccines. New generation vaccines. (pp. 315-326) edited by Myron M. Levine. New York, U.S.A.; London, U.K.: Informa Healthcare. doi: 10.3109/9781420060744-32

Lipopeptide-based vaccines

2010

Journal Article

Thymine, adenine and lipoamino acid based gene delivery systems

Skwarczynski, Mariusz, Ziora, Zyta M., Coles, Daniel J., Lin, I-Chun and Toth, Istvan (2010). Thymine, adenine and lipoamino acid based gene delivery systems. Chemical Communications, 46 (18), 3140-3142. doi: 10.1039/b924371b

Thymine, adenine and lipoamino acid based gene delivery systems

2009

Journal Article

Development of conformational mimetics of conserved Streptococcus pyogenes minimal epitope as vaccine candidates

Zhong, Wei, Skwarczynski, Mariusz and Toth, Istvan (2009). Development of conformational mimetics of conserved Streptococcus pyogenes minimal epitope as vaccine candidates. Current Drug Delivery, 6 (5), 520-527. doi: 10.2174/156720109789941650

Development of conformational mimetics of conserved Streptococcus pyogenes minimal epitope as vaccine candidates